Published in
American Society for Pharmacology and Experimental Therapeutics (ASPET), Molecular Pharmacology, 1(82), p. 134-141, 2012
Links
Tools
The polyphenolic ellagitannin vescalagin acts as a preferential catalytic inhibitor of the $α$ isoform of human DNA topoisomerase II
Journal article published in 2012 by
Céline Auzanneau,
Danièle Montaudon,
Rémi Jacquet,
Stéphane Puyo,
Laurent Pouységu,
Denis Deffieux,
Assia Elkaoukabi-Chaibi,
Francesca De Giorgi 
,
François Ichas ,
Stéphane Quideau,
Philippe Pourquier
,
François Ichas ,
Stéphane Quideau,
Philippe Pourquier
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 